Roche Holding AG (RHHBF OTCQX) stock market data APIs
$494.3817
7.27(1.5%)
as of November 2, 2026
Try our APIs with
free plan!
Roche Holding AG Financial Data Overview
Price chart is built with
Anychart
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
Prev. Close
494.3817
Open
501.6535
High
504.9079
Low
493.3916
52 wk Range
326.1705-505
Market Cap
402 367 M
P/E Ratio
25.6215
Shares Outstanding
107 M
Revenue
62 959 M
EPS
4.8905
Dividends (Yield)
0.0196
Beta
0.324
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roche Holding AG (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding AG data using free add-ons & libraries
Get Roche Holding AG Fundamental Data
Roche Holding AG Fundamental data includes:
- Net Revenue: 62 959 M
- EBITDA: 23 964 M
- Earnings Per Share: 19
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-04-21
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding AG News
New
Biophotonics - Global Strategic Business Report 2026: Secure Share of a US$130.6 Billion Market by 2032, Led by Roche, GE Healthcare, Horiba, and IPG Photonics
Company Logo Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Biophotonics - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global biophotonics market was ...
RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines
Company Logo AI-driven screening, RNA-focused libraries and pharma-biotech partnerships accelerate drug discovery and unlock opportunities in oncology, rare diseases and infectious diseases. Dublin,...
SIG vs. CFRUY: Which Stock Is the Better Value Option?
Investors interested in Retail - Jewelry stocks are likely familiar with Signet (SIG) and Compagnie Financiere Richemont AG (CFRUY). But which of these two companies is the best option for those looki...
Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption
Company Logo R&D investment, CRISPR, NGS, personalized medicine and diagnostics drive demand, while strategic partnerships accelerate reagent innovation and commercialization. Dublin, Nov. 02, 2026 ...
Get Roche Holding AG fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.